Director, Scientific Writing

Role: Director, Scientific Writing within AstraZeneca’s Oncology Medical Affairs, leading a high-performing team to produce scientifically rigorous research outputs for interventional trials (Phases II-IV) and real-world studies. Objectives include developing protocols, authoring and overseeing study reports, abstracts, posters, and HTA dossiers, and driving AI-augmented writing initiatives. Responsibilities encompass managing budgets and contractor relationships, collaborating across Oncology Outcomes Research and Evidence Delivery teams, and representing the Scientific Writing function at leadership levels. Qualifications: advanced degree in a scientific or medical field (e.g., PharmD, PhD, MD), with at least 7 years’ scientific writing experience, including in pharma or medical communications. Demonstrated expertise in publication management, drug development, and AI tools (e.g., Claude, Copilot, Gemini), with an understanding of regulatory and GxP standards. Preferred: oncology therapeutic knowledge, certification as a Medical Publication Professional (CMPP), and experience scaling AI-enabled workflows. High-Value: focus on oncology, late-phase clinical trials, real-world evidence, AI-driven processes, and cross-functional leadership. Work setup: in-office hybrid model with ongoing flexibility, based in a global organization.